Gilead

Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Mon, 01/9/12 - 09:57 am
hepatitis C
Bristol-Myers Squibb
M&A
Inhibitex
Gilead
Pharmasset
The Magic Formula for Biotech
Motley Fool
Sun, 01/8/12 - 12:50 pm
Gilead
Amgen
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Pharmasset: M&A Presents Interesting Options Plays
Seeking Alpha
Wed, 01/4/12 - 09:36 am
M&A
Pharmasset
Gilead
Fate on Gilead Quad Set for Aug '12
Yahoo/Zacks
Wed, 12/28/11 - 06:15 pm
Quad
Gilead
HIV
FDA
Pharma winners of 2011 could keep surging next year
Investorplace
Wed, 12/28/11 - 12:08 pm
Amgen
Biogen Idec
Celgene
Gilead
Pharmasset
Alexion
Regeneron
Recent Performance Review Of 5 Large Cap Biotech Equities
Seeking Alpha
Tue, 12/27/11 - 12:36 pm
Alexion
Amgen
Biogen Idec
Celgene
Gilead
Merck
Pfizer
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
4 Biotech Stocks With Consistently Rising EPS
Seeking Alpha
Thu, 12/22/11 - 09:16 am
Amgen
Biogen Idec
Gilead
Illumina
Health Care's Hottest Duo
Motley Fool
Wed, 12/21/11 - 09:01 am
Gilead
Pharmasset
hepatitis C
Achillion
Inhibitex
Gilead Sciences And Its HIV Prevention-In-A-Pill
Pharmalot
Mon, 12/19/11 - 10:03 am
HIV
Gilead
Truvada
Hep C Drug Panic! Pharmasset Stumble Ripples Through Sector
TheStreet.com
Fri, 12/16/11 - 11:29 am
Pharmasset
hepatitis C
Gilead
Inhibitex
PSI-938
Indenix
Pharmasset Says Drug Trial Change Won’t Affect Gilead Takeover Agreement
Bloomberg
Fri, 12/16/11 - 11:26 am
Pharmasset
Gilead
M&A
hepatitis C
PSI-938
Gilead Reports Non-inferior Data From Phase 3 Study Of Elvitegravir In HIV
NASDAQ.com
Fri, 12/9/11 - 12:02 pm
HIV
Gilead
elvitegravir
4 Reasons Inhibitex Is No Longer A Good Buy
Seeking Alpha
Wed, 12/7/11 - 11:42 am
Inhibitex
INX-189
Gilead
hepatitis C
Pharmasset
Pharmasset Poised to Pay 20% on Gilead Closing in First Quarter: Real M&A
Bloomberg
Mon, 12/5/11 - 10:14 pm
Pharmasset
Gilead
M&A
PSI-7977
hepatitis C
Why Large Cap Healthcare Multiples Should Expand
Seeking Alpha
Thu, 12/1/11 - 12:10 pm
Abbott Laboratories
Gilead
JNJ
Merck
Medtronic
Medicis
Pfizer
5 Risky Biotechs With Serious Profit Potential
Seeking Alpha
Tue, 11/29/11 - 01:37 pm
Amgen
Gilead
Spectrum Pharmaceuticals
InterMune
ViroPharma
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Mon, 11/28/11 - 11:38 am
Gilead
Pharmasset
M&A
hepatitis C
GSK
JNJ
Bristol-Myers Squibb
PSI-7977
Vertex
HIV
Gilead could have had Pharmasset cheap: founder
Reuters
Wed, 11/23/11 - 09:23 am
Pharmasset
Gilead
M&A

Pages